. Earth Science News .
EPIDEMICS
Virus stigma weighs heavily in sub-Saharan Africa
by Staff Writers
Libreville, Nigeria (SPX) May 20, 2020

.

Landlords evict people from their homes, nurses are abandoned by their husbands and people are spurned just on suspicion of coming into contact with a COVID-19 patient.

Across sub-Saharan Africa, the stigma attached to the coronavirus is so strong that some choose not to seek treatment to avoid facing unbearable hostility.

People suspected of having contracted COVID-19 say they are treated like pariahs: singled out at work, in their neighbourhoods and even in their homes.

Fatou, a Senegalese woman in her twenties who did not use her real name, described her bitter experience about a month ago after coming into contact with a sick person.

She was immediately confined to her room and ostracised by people in her community.

"Messages have been circulating on social media with my first name, surname and address," she said, adding that rumours were spread that she "contracted the virus by sleeping with white people".

Fatou, who was confined to her room until she tested negative, was then forced to spend two weeks in isolation in a hotel despite having no symptoms because the doctors tracking her case had received "anonymous calls", she said.

This at least gave her a respite "from the gossip", she said.

Some 3,000 kilometres (1,800 miles) away in Gabon, Jocelyn, a biologist who tests suspect cases in Libreville, said he is subjected to similar discrimination on a daily basis.

His team tries to keep a low profile when they visit homes, even if it means endangering their own health.

"We put our suits on inside rather than on the front steps," he said.

"The Gabonese people panic at the idea of us coming to their homes," he added.

- Psychological cost -
In neighbouring Cameroon, a landlord evicted a tenant who tested positive for coronavirus, Yap Boum, an epidemiologist in Yaounde, told AFP.

The stigma attached to the virus is not unique to Africa. "But here we tend to be more communal, we know our neighbours," Boum said.

Many people prefer to keep to themselves when they develop symptoms. Some have died because they delayed seeking medical treatment for fear of being associated with the virus, according to Boum, who is the director of Doctors Without Borders' African research centre.

"The psychological aspect must be taken into account if we want to win this battle," he said.

Caregivers in particular are often treated like "plague victims", Boum said.

Cameroonian nurses have been left by their husbands, driven out of their homes because they were working in coronavirus units, said Laure Menguene Mviena, who heads a psychological response unit for COVID-19 patients in Yaounde.

"It is urgent to assist them psychologically because if they are mentally and physically exhausted, how will they care for others?" she stressed.

People should realise that the mortality rate is still low in Cameroon, "lower than in Europe," Menguene Mviena said.

Only around 1,400 deaths from the coronavirus have been reported in sub-Saharan Africa.

- Nicknamed 'Corona' -
Some patients continue to be shamed even after they have recovered from the virus, with many believing they are still endangering public health.

After Roselyn Nyambura of Kenya was released from hospital, her neighbours mocked her and stared at her, she said.

Some even went so far as to call her "Corona".

Once people around her had more information about the disease, the scathing comments began to cease.

"With the intervention of elders, local authorities and the church, people have started to understand that it is possible to recover from corona," she said.

The Kenyan government needs to do more to educate people about the virus, she said.

Governments must strike a delicate balance between the need to enforce strict anti-infection measures while tamping down the fearfulness that leads to stigmatisation.

During the Ebola epidemic - which killed more than one-third of the people it infected in Liberia, Guinea and Sierra Leone in 2014 - survivors were in a similar position, Boum said.

Recovered patients were issued certificates stating that they did not pose any further risk to the community than other citizens.

In fact, there is little upside to being a coronavirus survivor, notably in the absence of evidence that a healed patient is immune, even temporarily.

In Nigeria, public health announcements have hammered home the message that stigmatising survivors is wrong and that coronavirus "is not a death sentence".

But scepticism persists.

Somalians run into trouble just for wearing a protective mask.

Mohamed Sharif, a driver in Mogadishu, must wear one for work and has noticed that people avoid him and even flee as he approaches.

"Sometimes you are humiliated by others who think because of the mask you have coronavirus," he said. "I remove it sometimes to avoid this humiliation."


Related Links
Africa News
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


EPIDEMICS
Injection better at HIV protection than daily pills: US researchers
Washington (AFP) May 18, 2020
Injecting people with a new, experimental drug every eight weeks provides better protection against HIV than daily pills that have revolutionized the fight against AIDS, US government researchers reported Monday. The National Institutes of Health released the preliminary results of a major clinical trial involving a drug called cabotegravir. The testing began more than three years ago in seven countries - including the United States, Brazil, Thailand and South Africa - and looked at men who have ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
Virus-isolated silver surfers ride a new tech wave

Amazon calls for US federal law to ban price gouging

Facebook apologises for role in 2018 Sri Lanka unrest

Buzz off: Italian start-up offers social distancing bracelets

EPIDEMICS
Ultra-long-working-distance spectroscopy with 3D-printed aspherical microlenses

New algorithm predicts optimal materials among all possible compounds

German 3D printing buffs pitch in with virus-fighting network

Russian Meteor-M satellite resumes work after meteoroid strike

EPIDEMICS
Shrub encroachment on grasslands can increase groundwater recharge

Scientists successfully develop 'heat resistant' coral to fight bleaching

Sudan rejects Ethiopia's proposal to fill mega-dam

Five surfers die in Dutch beach tragedy

EPIDEMICS
Researchers go 'cuckoo' over Antarctic penguin poop

Antarctica's splendid isolation keeps coronavirus at bay

New technique uses radar to gauge methane release from Arctic lakes

US Navy ships in Barents Sea near Russia, 1st time since 1980s

EPIDEMICS
India's 'superfood' jackfruit goes global

Australia 'disappointed' by China barley tariffs

Global cooling event 4,200 years ago spurred rice's evolution, spread across Asia

Oyster farming has a limited impact on vulnerable shorebirds

EPIDEMICS
Four dead after earthquake in southwest China

Virus fears as India, Bangladesh evacuate millions ahead of cyclone

Quake with 6.4 magnitude hits desert area on Nevada-California border

Powerful storm forces thousands from homes in virus-hit Philippines

EPIDEMICS
Quarter of a billion Africans at risk, as virus toll tops 300,000

AFRICOM, U.S. Army conduct vehicle maintenance training in Senegal

Misinformation flood hampers fight for virus vaccine in Africa

French foreign legionnaires slain in Mali honoured in deserted Paris

EPIDEMICS
Early humans thrived in this drowned South African landscape

Early hominins in China adapted to changing climate with new technology

The oldest Upper Paleolithic Homo sapiens in Europe

Neanderthals preferred bovine bones for leather-making tools









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.